Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals Research and Development Expenses 2010-2025 | VRTX

Vertex Pharmaceuticals annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Vertex Pharmaceuticals research and development expenses for the quarter ending March 31, 2025 were $0.980B, a 24.15% increase year-over-year.
  • Vertex Pharmaceuticals research and development expenses for the twelve months ending March 31, 2025 were $3.821B, a 19.05% increase year-over-year.
  • Vertex Pharmaceuticals annual research and development expenses for 2024 were $3.63B, a 14.78% increase from 2023.
  • Vertex Pharmaceuticals annual research and development expenses for 2023 were $3.163B, a 24.51% increase from 2022.
  • Vertex Pharmaceuticals annual research and development expenses for 2022 were $2.54B, a 31.09% increase from 2021.
  
Vertex Pharmaceuticals Annual Research and Development Expenses
(Millions of US $)
2024 $3,630
2023 $3,163
2022 $2,540
2021 $1,938
2020 $1,645
2019 $1,755
2018 $1,416
2017 $1,325
2016 $1,048
2015 $996
2014 $856
2013 $882
2012 $766
2011 $708
2010 $637
2009 $550
Vertex Pharmaceuticals Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31 $980
2024-12-31 $999
2024-09-30 $876
2024-06-30 $967
2024-03-31 $789
2023-12-31 $825
2023-09-30 $810
2023-06-30 $786
2023-03-31 $743
2022-12-31 $694
2022-09-30 $645
2022-06-30 $600
2022-03-31 $601
2021-12-31 $566
2021-09-30 $467
2021-06-30 $449
2021-03-31 $456
2020-12-31 $282
2020-09-30 $493
2020-06-30 $421
2020-03-31 $449
2019-12-31 $480
2019-09-30 $556
2019-06-30 $379
2019-03-31 $339
2018-12-31 $438
2018-09-30 $331
2018-06-30 $338
2018-03-31 $311
2017-12-31 $307
2017-09-30 $455
2017-06-30 $289
2017-03-31 $274
2016-12-31 $248
2016-09-30 $272
2016-06-30 $271
2016-03-31 $256
2015-12-31 $310
2015-09-30 $246
2015-06-30 $224
2015-03-31 $216
2014-12-31 $201
2014-09-30 $191
2014-06-30 $224
2014-03-31 $239
2013-12-31 $222
2013-09-30 $219
2013-06-30 $222
2013-03-31 $218
2012-12-31 $173
2012-09-30 $200
2012-06-30 $197
2012-03-31 $196
2011-12-31 $186
2011-09-30 $189
2011-06-30 $174
2011-03-31 $159
2010-12-31 $169
2010-09-30 $170
2010-06-30 $155
2010-03-31 $143
2009-12-31 $135
2009-09-30 $132
2009-06-30 $139
2009-03-31 $144
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $115.628B $11.020B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $218.767B 16.33
Amgen (AMGN) United States $149.208B 13.37
Gilead Sciences (GILD) United States $133.349B 13.85
Bristol Myers Squibb (BMY) United States $95.710B 6.41
GSK (GSK) United Kingdom $79.191B 9.48
CSL (CSLLY) Australia $76.806B 0.00
Regeneron Pharmaceuticals (REGN) United States $56.387B 13.69
Alnylam Pharmaceuticals (ALNY) United States $42.376B 0.00
Argenex SE (ARGX) Netherlands $34.686B 94.68
BioNTech SE (BNTX) Germany $25.263B 0.00
Royalty Pharma (RPRX) United States $20.319B 8.58
Insmed (INSM) United States $20.091B 0.00
Biogen (BIIB) United States $18.508B 7.98
Illumina (ILMN) United States $14.488B 27.48
Genmab (GNMSF) Denmark $13.948B 14.26
Incyte (INCY) United States $13.358B 101.49
Genmab (GMAB) Denmark $13.299B 14.92
Exelixis (EXEL) United States $12.468B 21.17
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $11.349B 0.00
Ascendis Pharma (ASND) Denmark $10.949B 0.00
QIAGEN (QGEN) Netherlands $10.499B 20.43
BioMarin Pharmaceutical (BMRN) United States $10.488B 17.04
Moderna (MRNA) United States $10.365B 0.00
Exact Sciences (EXAS) United States $9.653B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $9.633B 24.60
Blueprint Medicines (BPMC) United States $8.283B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.277B 0.00
Roivant Sciences (ROIV) United Kingdom $7.845B 0.00
Bio-Techne Corp (TECH) United States $7.838B 29.24
Revolution Medicines (RVMD) United States $7.456B 0.00
Repligen (RGEN) United States $6.930B 77.58
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.642B 12.71
Jazz Pharmaceuticals (JAZZ) Ireland $6.542B 6.42
Legend Biotech (LEGN) United States $6.303B 0.00
Guardant Health (GH) United States $6.193B 0.00
TG Therapeutics (TGTX) United States $5.922B 155.42
Telix Pharmaceuticals (TLX) Australia $5.551B 0.00
Nuvalent (NUVL) United States $5.521B 0.00
Axsome Therapeutics (AXSM) United States $5.133B 0.00
Alkermes (ALKS) Ireland $4.840B 12.99
Vaxcyte (PCVX) United States $4.398B 0.00
Akero Therapeutics (AKRO) United States $4.298B 0.00
ADMA Biologics Inc (ADMA) United States $4.261B 31.88
Krystal Biotech (KRYS) United States $4.152B 32.00
Zai Lab (ZLAB) China $4.146B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.050B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.040B 0.00
Zealand Pharma (ZLDPF) Denmark $4.024B 0.00
Cytokinetics (CYTK) United States $3.989B 0.00
PTC Therapeutics (PTCT) United States $3.933B 6.84
ACADIA Pharmaceuticals (ACAD) United States $3.751B 32.96
Merus (MRUS) Netherlands $3.747B 0.00
Avidity Biosciences (RNA) United States $3.600B 0.00
SpringWorks Therapeutics (SWTX) United States $3.538B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.513B 0.00
Arcellx (ACLX) United States $3.491B 0.00
Anbio Biotechnology (NNNN) Germany $3.465B 0.00
Ascentage Pharma Group - (AAPG) China $3.459B 0.00
Protagonist Therapeutics (PTGX) United States $3.327B 71.57
Scholar Rock Holding (SRRK) United States $3.172B 0.00
Metsera (MTSR) United States $3.079B 0.00
Kymera Therapeutics (KYMR) United States $3.070B 0.00
Viking Therapeutics (VKTX) United States $3.027B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.929B 0.00
Alvotech (ALVO) Luxembourg $2.780B 15.90
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.761B 0.00
Immunovant (IMVT) United States $2.735B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.532B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.469B 0.00
ImmunityBio (IBRX) United States $2.463B 0.00
Apellis Pharmaceuticals (APLS) United States $2.339B 0.00
Ligand Pharmaceuticals (LGND) United States $2.281B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.204B 0.00
Vericel (VCEL) United States $2.182B 1444.67
Twist Bioscience (TWST) United States $2.148B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.122B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.121B 0.00
Denali Therapeutics (DNLI) United States $2.092B 0.00
Bavarian Nordic (BVNRY) Denmark $2.077B 10.98
Apogee Therapeutics (APGE) United States $2.005B 0.00
CG Oncology (CGON) United States $1.967B 0.00
Agios Pharmaceuticals (AGIO) United States $1.936B 0.00
IDEAYA Biosciences (IDYA) United States $1.908B 0.00
Disc Medicine (IRON) United States $1.905B 0.00
Belite Bio (BLTE) United States $1.900B 0.00
NovoCure (NVCR) Jersey $1.895B 0.00
Sarepta Therapeutics (SRPT) United States $1.865B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.841B 12.24
Amicus Therapeutics (FOLD) United States $1.758B 190.33
Tarsus Pharmaceuticals (TARS) United States $1.739B 0.00
Certara (CERT) United States $1.734B 32.39
Beam Therapeutics (BEAM) United States $1.725B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.708B 0.00
Adaptive Biotechnologies (ADPT) United States $1.618B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.608B 0.00
GRAIL (GRAL) United States $1.581B 0.00
Edgewise Therapeutics (EWTX) United States $1.552B 0.00
Biohaven (BHVN) United States $1.508B 0.00
ANI Pharmaceuticals (ANIP) United States $1.451B 14.95
Vera Therapeutics (VERA) United States $1.440B 0.00
Celldex Therapeutics (CLDX) United States $1.437B 0.00
89BIO (ETNB) United States $1.433B 0.00
Janux Therapeutics (JANX) United States $1.382B 0.00
Travere Therapeutics (TVTX) United States $1.353B 0.00
Mesoblast (MESO) Australia $1.335B 0.00
Structure Therapeutics (GPCR) United States $1.283B 0.00
BGM Group (BGM) China $1.255B 0.00
MannKind (MNKD) United States $1.213B 24.94
CureVac (CVAC) Germany $1.202B 5.83
Viridian Therapeutics (VRDN) United States $1.196B 0.00
Dynavax Technologies (DVAX) United States $1.190B 70.79
Liquidia Technologies (LQDA) United States $1.178B 0.00
Pacira BioSciences (PCRX) United States $1.140B 10.85
Niagen Bioscience (NAGE) United States $1.113B 157.00
AbCellera Biologics (ABCL) Canada $1.098B 0.00
CorMedix Inc (CRMD) United States $1.066B 71.46
WAVE Life Sciences (WVE) Singapore $1.062B 0.00
Novavax (NVAX) United States $1.051B 2.45
Intellia Therapeutics (NTLA) United States $0.991B 0.00
Geron (GERN) United States $0.987B 0.00
NeoGenomics (NEO) United States $0.930B 0.00
Spyre Therapeutics (SYRE) United States $0.929B 0.00
Arcus Biosciences (RCUS) United States $0.926B 0.00
Mineralys Therapeutics (MLYS) United States $0.922B 0.00
Nurix Therapeutics (NRIX) United States $0.913B 0.00
Pharvaris (PHVS) Netherlands $0.899B 0.00
Praxis Precision Medicines (PRAX) United States $0.895B 0.00
Oric Pharmaceuticals (ORIC) United States $0.894B 0.00
Zymeworks (ZYME) United States $0.892B 0.00
MiMedx (MDXG) United States $0.880B 21.29
Oculis Holding AG (OCS) Switzerland $0.862B 0.00
LENZ Therapeutics (LENZ) United States $0.838B 0.00
Cogent Biosciences (COGT) United States $0.824B 0.00
Anavex Life Sciences (AVXL) United States $0.816B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.793B 0.00
ArriVent BioPharma (AVBP) United States $0.791B 0.00
UniQure (QURE) Netherlands $0.779B 0.00
Immunome (IMNM) United States $0.776B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Pharming Group (PHAR) Netherlands $0.762B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Replimune (REPL) United States $0.752B 0.00
Vir Biotechnology (VIR) United States $0.729B 0.00
Gyre Therapeutics (GYRE) United States $0.713B 190.25
Sionna Therapeutics (SION) United States $0.708B 0.00
Nuvation Bio (NUVB) United States $0.698B 0.00
AnaptysBio (ANAB) United States $0.685B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.681B 0.00
Trevi Therapeutics (TRVI) United States $0.677B 0.00
Sana Biotechnology (SANA) United States $0.670B 0.00
Immatics (IMTX) Germany $0.661B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.657B 0.00
GH Research (GHRS) Ireland $0.652B 0.00
Arbutus Biopharma (ABUS) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Urogen Pharma (URGN) United States $0.636B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.632B 0.00
Stoke Therapeutics (STOK) United States $0.628B 14.57
Iovance Biotherapeutics (IOVA) United States $0.628B 0.00
Upstream Bio (UPB) United States $0.613B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.604B 0.00
Cidara Therapeutics (CDTX) United States $0.588B 0.00
Dianthus Therapeutics (DNTH) United States $0.583B 0.00
Tango Therapeutics (TNGX) United States $0.581B 0.00
Sage Therapeutics (SAGE) United States $0.577B 0.00
Arvinas (ARVN) United States $0.565B 0.00
Keros Therapeutics (KROS) United States $0.557B 0.00
Castle Biosciences (CSTL) United States $0.553B 37.57
Mind Medicine (MindMed) (MNMD) United States $0.540B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.538B 0.00
Opthea (OPT) Australia $0.525B 0.00
Bicara Therapeutics (BCAX) United States $0.519B 0.00
Kura Oncology (KURA) United States $0.518B 0.00
MeiraGTx Holdings (MGTX) United States $0.518B 0.00
Tyra Biosciences (TYRA) United States $0.517B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.506B 0.00
Fortrea Holdings (FTRE) United States $0.481B 13.27
Septerna (SEPN) United States $0.477B 0.00
ATyr Pharma (ATYR) United States $0.473B 0.00
Myriad Genetics (MYGN) United States $0.466B 0.00
Cullinan Therapeutics (CGEM) United States $0.463B 0.00
Celcuity (CELC) United States $0.460B 0.00
Kamada (KMDA) Israel $0.457B 27.41
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
Maze Therapeutics (MAZE) United States $0.452B 0.00
Rapport Therapeutics (RAPP) United States $0.452B 0.00
Precigen (PGEN) United States $0.443B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.432B 0.00
PureTech Health (PRTC) United States $0.432B 0.00
REGENXBIO (RGNX) United States $0.429B 0.00
Abivax SA (ABVX) France $0.422B 0.00
Zenas BioPharma (ZBIO) United States $0.419B 0.00
Erasca (ERAS) United States $0.411B 0.00
Cytek Biosciences (CTKB) United States $0.409B 0.00
Benitec Biopharma (BNTC) United States $0.393B 0.00
Fulcrum Therapeutics (FULC) United States $0.388B 0.00
ITeos Therapeutics (ITOS) United States $0.386B 0.00
Tectonic Therapeutic (TECX) United States $0.377B 0.00
Solid Biosciences (SLDB) United States $0.376B 0.00
Northwest Biotherapeutics (NWBO) United States $0.376B 0.00
Vigil Neuroscience (VIGL) United States $0.370B 0.00
MBX Biosciences (MBX) United States $0.369B 0.00
Emergent Biosolutions (EBS) United States $0.367B 0.00
Eton Pharmaceuticals (ETON) United States $0.364B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.364B 0.00
Rezolute (RZLT) United States $0.363B 0.00
Compass Therapeutics (CMPX) United States $0.362B 0.00
Absci (ABSI) United States $0.358B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.356B 0.00
Humacyte (HUMA) United States $0.346B 0.00
Aardvark Therapeutics (AARD) United States $0.342B 0.00
Amarin (AMRN) Ireland $0.332B 0.00
Terns Pharmaceuticals (TERN) United States $0.331B 0.00
XOMA Royalty (XOMA) United States $0.330B 0.00
Aura Biosciences (AURA) United States $0.329B 0.00
Prothena (PRTA) Ireland $0.327B 0.00
Astria Therapeutics (ATXS) United States $0.325B 0.00
Prime Medicine (PRME) United States $0.323B 0.00
Olema Pharmaceuticals (OLMA) United States $0.321B 0.00
Gossamer Bio (GOSS) United States $0.314B 0.00
Lifecore Biomedical (LFCR) United States $0.307B 0.00
Ocugen (OCGN) United States $0.302B 0.00
Sagimet Biosciences (SGMT) United States $0.302B 0.00
Abeona Therapeutics (ABEO) United States $0.300B 0.00
Inventiva S.A (IVA) France $0.299B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.296B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.296B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.292B 59.25
Atea Pharmaceuticals (AVIR) United States $0.289B 0.00
Alpha Teknova (TKNO) United States $0.288B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.278B 0.00
Allogene Therapeutics (ALLO) United States $0.273B 0.00
Foghorn Therapeutics (FHTX) United States $0.271B 0.00
Cartesian Therapeutics (RNAC) United States $0.269B 0.00
Annexon (ANNX) United States $0.269B 0.00
Entrada Therapeutics (TRDA) United States $0.269B 8.74
Tvardi Therapeutics (TVRD) United States $0.267B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.265B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Verastem (VSTM) United States $0.251B 0.00
Neurogene (NGNE) United States $0.245B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Palvella Therapeutics (PVLA) United States $0.244B 0.00
Candel Therapeutics (CADL) United States $0.243B 0.00
MaxCyte (MXCT) United States $0.236B 0.00
Prima BioMed (IMMP) Australia $0.234B 0.00
DBV Technologies S.A (DBVT) France $0.233B 0.00
Adherex Technologies (FENC) United States $0.233B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.232B 0.00
BioStem Technologies (BSEM) $0.226B 9.22
Design Therapeutics (DSGN) United States $0.225B 0.00
Semper Paratus Acquisition (TVGN) United States $0.217B 0.00
Inhibrx Biosciences (INBX) United States $0.214B 0.13
ProQR Therapeutics (PRQR) Netherlands $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Cardiff Oncology (CRDF) United States $0.213B 0.00
AC Immune (ACIU) Switzerland $0.211B 0.00
ScPharmaceuticals (SCPH) United States $0.209B 0.00
Codexis (CDXS) United States $0.207B 0.00
Monopar Therapeutics (MNPR) United States $0.204B 0.00
Bright Minds Biosciences (DRUG) United States $0.197B 0.00
I-Mab (IMAB) United States $0.194B 0.00
CARGO Therapeutics (CRGX) United States $0.193B 0.00
GENFIT S.A (GNFT) France $0.192B 0.00
Kodiak Sciences (KOD) United States $0.190B 0.00
Citius Oncology (CTOR) United States $0.190B 0.00
Editas Medicine (EDIT) United States $0.188B 0.00
Instil Bio (TIL) United States $0.187B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.185B 0.00
SELLAS Life Sciences (SLS) United States $0.177B 0.00
CytomX Therapeutics (CTMX) United States $0.173B 4.46
Ventyx Biosciences (VTYX) United States $0.172B 0.00
Puma Biotechnology (PBYI) United States $0.167B 4.36
Nuvectis Pharma (NVCT) United States $0.167B 0.00
Voyager Therapeutics (VYGR) United States $0.166B 0.00
Innate Pharma S.A (IPHA) France $0.165B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.165B 0.00
Alumis (ALMS) United States $0.164B 0.00
Anika Therapeutics (ANIK) United States $0.161B 0.00
Spero Therapeutics (SPRO) United States $0.161B 0.00
BioAge Labs (BIOA) United States $0.161B 0.00
DiaMedica Therapeutics (DMAC) United States $0.160B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.156B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.156B 0.00
EnGene Holdings (ENGN) Canada $0.153B 0.00
INmune Bio (INMB) United States $0.152B 0.00
Compugen (CGEN) Israel $0.152B 0.00
Alector (ALEC) United States $0.149B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Alpha Cognition (ACOG) Canada $0.142B 0.00
Black Diamond Therapeutics (BDTX) United States $0.142B 41.50
Kyverna Therapeutics (KYTX) United States $0.138B 0.00
Agenus (AGEN) United States $0.137B 0.00
Rapt Therapeutics (RAPT) United States $0.136B 0.00
Fate Therapeutics (FATE) United States $0.134B 0.00
Actuate Therapeutics (ACTU) United States $0.132B 0.00
Caribou Biosciences (CRBU) United States $0.131B 0.00
Neumora Therapeutics (NMRA) United States $0.131B 0.00
Elicio Therapeutics (ELTX) United States $0.129B 0.00
Nkarta (NKTX) United States $0.124B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.123B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.122B 0.00
Greenwich LifeSciences (GLSI) United States $0.121B 0.00
Sangamo Therapeutics (SGMO) United States $0.120B 0.00
Contineum Therapeutics (CTNM) United States $0.117B 0.00
Seer (SEER) United States $0.116B 0.00
23andMe Holding (MEHCQ) United States $0.115B 0.00
BioHarvest Sciences (BHST) Canada $0.113B 0.00
Theratechnologies (THTX) Canada $0.112B 0.00
Skye Bioscience (SKYE) United States $0.112B 0.00
C4 Therapeutics (CCCC) United States $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.107B 0.00
Tenaya Therapeutics (TNYA) United States $0.106B 0.00
Immuneering (IMRX) United States $0.106B 0.00
Genelux (GNLX) United States $0.105B 0.00
TuHURA Biosciences (HURA) United States $0.103B 0.00
BeyondSpring (BYSI) United States $0.099B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.097B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.096B 0.00
HilleVax (HLVX) United States $0.095B 0.00
TScan Therapeutics (TCRX) United States $0.095B 0.00
Forte Biosciences (FBRX) United States $0.093B 0.00
Adagene (ADAG) China $0.092B 0.00
IO Biotech (IOBT) Denmark $0.092B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
Invivyd (IVVD) United States $0.090B 0.00
Cabaletta Bio (CABA) United States $0.090B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Whitehawk Therapeutics (WHWK) United States $0.089B 0.00
Coherus Oncology (CHRS) United States $0.089B 0.00
Climb Bio (CLYM) United States $0.087B 0.00
EXoZymes (EXOZ) United States $0.086B 0.00
Jasper Therapeutics (JSPR) United States $0.084B 0.00
Zura Bio (ZURA) United States $0.083B 0.00
Cellectis S.A (CLLS) France $0.082B 0.00
XBiotech (XBIT) United States $0.081B 0.00
Pliant Therapeutics (PLRX) United States $0.080B 0.00
Quantum Biopharma (QNTM) Canada $0.079B 0.00
OKYO Pharma (OKYO) $0.078B 0.00
TELA Bio (TELA) United States $0.076B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.076B 0.00
Inovio Pharmaceuticals (INO) United States $0.076B 0.00
Seres Therapeutics (MCRB) United States $0.074B 0.00
PDS Biotechnology (PDSB) United States $0.073B 0.00
Elutia (ELUT) United States $0.071B 0.00
Biomea Fusion (BMEA) United States $0.071B 0.00
IGM Biosciences (IGMS) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.069B 0.00
Immunic (IMUX) United States $0.068B 0.00
Alto Neuroscience (ANRO) United States $0.068B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.067B 0.00
MediciNova (MNOV) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
Quince Therapeutics (QNCX) United States $0.066B 0.00
Clearside Biomedical (CLSD) United States $0.065B 0.00
Oncolytics Biotech (ONCY) Canada $0.064B 0.00
Akoya Biosciences (AKYA) United States $0.062B 0.00
Immix Biopharma (IMMX) United States $0.062B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.062B 0.00
Renovaro (RENB) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.061B 0.00
Repare Therapeutics (RPTX) Canada $0.061B 0.00
Annovis Bio (ANVS) United States $0.060B 0.00
Oncobiologics (OTLK) United States $0.059B 0.00
CervoMed (CRVO) United States $0.059B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
Werewolf Therapeutics (HOWL) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.055B 0.00
Opus Genetics (IRD) United States $0.055B 0.00
Cue Biopharma (CUE) United States $0.055B 0.00
Adicet Bio (ACET) United States $0.054B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
Connect Biopharma Holdings (CNTB) United States $0.053B 0.00
Adverum Biotechnologies (ADVM) United States $0.053B 0.00
Fortress Biotech (FBIO) United States $0.053B 0.00
Senti Biosciences (SNTI) United States $0.052B 0.00
RenovoRx (RNXT) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
Aligos Therapeutics (ALGS) United States $0.050B 0.00
Shattuck Labs (STTK) United States $0.050B 0.00
Atara Biotherapeutics (ATRA) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.047B 0.00
Applied Therapeutics (APLT) United States $0.046B 0.00
Celularity (CELU) United States $0.046B 0.00
PepGen (PEPG) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Vor Biopharma (VOR) $0.040B 0.00
Alterity Therapeutics - (ATHE) Australia $0.039B 0.00
Artiva Biotherapeutics (ARTV) United States $0.039B 0.00
Scilex Holding (SCLX) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.037B 0.00
Clene (CLNN) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Exicure (XCUR) United States $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.036B 0.00
ABVC BioPharma (ABVC) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Estrella Immunopharma (ESLA) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
Pluri (PLUR) Israel $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.034B 0.00
CAMP4 Therapeutics (CAMP) United States $0.033B 0.00
Medicus Pharma (MDCX) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.032B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Rani Therapeutics Holdings (RANI) United States $0.029B 0.00
FibroBiologics (FBLG) United States $0.029B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.027B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
KALA BIO (KALA) United States $0.026B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Dare Bioscience (DARE) United States $0.024B 0.00
BioAtla (BCAB) United States $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
Curis (CRIS) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Cadrenal Therapeutics (CVKD) United States $0.022B 0.00
Passage Bio (PASG) United States $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
Q32 Bio (QTTB) United States $0.019B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Longeveron (LGVN) United States $0.019B 0.00
Aytu BioPharma (AYTU) United States $0.018B 0.00
Cingulate (CING) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Advanced Biomed (ADVB) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
HOOKIPA Pharma (HOOK) United States $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Imunon (IMNN) United States $0.016B 0.00
Rallybio (RLYB) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.013B 0.00
X4 Pharmaceuticals (XFOR) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Jade Biosciences (JBIO) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
GT Biopharma (GTBP) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Moleculin Biotech (MBRX) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00